Stylianos Michalakis is Professor for Ocular Gene Therapy at Ludwig-Maximillians-Universität, Munich. He has an outstanding track record and a recognized expertise in pre-clinical and translational retinal gene therapy products from discovery to phase II. Stylianos has more than 15 years of experience in gene therapy and extensive understanding of AAV vector design, engineering, production, gene therapy applications and is principal investigator and co-principal investigator on DFG and NIH grants for retinal gene therapy. He has authored over 100 peer-reviewed publications.
Stylianos has a Ph.D. in Pharmacology from LMU Munich and completed his postdoctoral fellowship at TUM and LMU.